Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -8.77x is 100% above its 5-year average of -3559.11x, near the high end of its 5-year range (-9541.57x–-1.64x).
Reported quarterly interest coverage; no daily interpolation. Q4 FY2025 (2025-12-31): -1.64x.
INTEREST COVERAGE RATIO
-8.77x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
-3559.11x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
+99.75%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
6.80x
median of 88 covered companies
CURRENT VS SECTOR MEDIAN
-228.97%
vs the sector median at left
Beam Therapeutics Inc.
Market Cap
$2.52B
Interest Coverage Ratio
-8.77x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
-3559.11x
Market Cap
$2.76B
Interest Coverage Ratio
7.88x
TTM Avg
5.24x
3Y Avg
5.24x
5Y Avg
5.24x
Market Cap
$2.16B
Interest Coverage Ratio
-358.08x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.74B
Interest Coverage Ratio
2.86x
TTM Avg
2.86x
3Y Avg
2.86x
5Y Avg
6.42x
Market Cap
$1.71B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.00B
Interest Coverage Ratio
-13.34x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$474.59M
Interest Coverage Ratio
-17.61x
TTM Avg
2.56x
3Y Avg
1.47x
5Y Avg
1.63x
Market Cap
$458.62M
Interest Coverage Ratio
4.74x
TTM Avg
9.15x
3Y Avg
25.82x
5Y Avg
26.16x
Market Cap
$394.23M
Interest Coverage Ratio
-375.67x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | $2.52B | -8.77x | N/A | N/A | -3559.11x |
| TransMedics Group, Inc. (TMDX)vs › | $2.76B | 7.88x | 5.24x | 5.24x | 5.24x |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.16B | -358.08x | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.74B | 2.86x | 2.86x | 2.86x | 6.42x |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.71B | N/A | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.00B | -13.34x | N/A | N/A | N/A |
| NeoGenomics, Inc. (NEO)vs › | $474.59M | -17.61x | 2.56x | 1.47x | 1.63x |
| NRC Health (NRC)vs › | $458.62M | 4.74x | 9.15x | 25.82x | 26.16x |
| Shoulder Innovations, Inc. (SI)vs › | $394.23M | -375.67x | N/A | N/A | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $41.86M | -5.91x | N/A | N/A | N/A |
Interest Coverage
-8.8x
Debt/Equity
0.23
Current Ratio
14.57
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-12-31 | -1.64x |
| 2021-06-30 | -1134.12x |
| 2021-03-31 | -9541.57x |
| 2020-06-30 | -50.84x |
| 2019-12-31 | -221.61x |
| 2019-09-30 | -257.49x |
